Endovascular Engineering
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3925 Bohannon Dr Ste 300, Menlo Park, Ca...Phone Number
(650) 407-5805Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Endovascular Engineering
Headquartered in Menlo Park, CA, Endovascular Engineering is a mission-driven, venture-backed company focused on the development and deployment of next generation clot removal technologies that target venous thromboembolism.Explore more
Endovascular Engineering Org Chart
Get the full picture
Sign in to uncover key details.
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Endovascular Engineering your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Endovascular Engineering has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Endovascular Engineering had a recent Job posting/layoffs
Product Launch: Get notified when Endovascular Engineering launches new products
Earning: See what the market has to say on Endovascular Engineering recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Endovascular Engineering
Website visits: Recent activity has been detected on your website
Endovascular Engineering, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Endovascular Engineering has recently received funding, and reach out quickly before it becomes old news!
Check out if Endovascular Engineering is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Endovascular Engineering as Masked Content
Find 2 more new buyers
Compare Similar Companies to Endovascular Engineering
Compare insights from companies similar to Endovascular Engineering, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Endovascular Engineering is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Endovascular Engineering is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Endovascular Engineering.
Endovascular Engineering financials insights
Gather financial insights about Endovascular Engineering, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series B
$42M
2026
Series C
$80M
Endovascular Engineering Tech Stack
A closer look at the technologies used by Endovascular Engineering
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Person-Based
Funding
Funding
Person-Based
Endovascular Engineering News & Media
Endovascular Engineering Announces Dual Late-Breaking Presentations at SIR and SCAI 2026 Highlighting Validation of Blood Return and Comprehensive ENGULF Study Results
MENLO PARK, Calif., March 19, 2026 /PRNewswire/ -- Endovascular Engineering, Inc. ("E2") today announced that two abstracts related to the ENGULF study and the Hēlo® Platform have been accepted as late-breaking podium presentations at the Society of Interventional Radiology (SIR) Annual...E2 (Endovascular Engineering, Inc) Presents ENGULF Pivotal Study as a Late-Breaking Clinical Trial at the VIVA Conference
Pivotal trial evaluated the safety and efficacy of the Hēlo™ Thrombectomy System for the removal of blood clots from the lungs MENLO PARK, Calif., Nov. 3, 2025 /PRNewswire/ -- Dr. Andrew Klein, ENGULF National Co-Principal Investigator at Piedmont Hospital in Atlanta, today presented the...E2 (Endovascular Engineering, Inc.) Appoints Justin Farry as Chief Financial Officer to Support Next Phase of Growth
MENLO PARK, Calif., Sept. 2, 2025 /PRNewswire/ -- E2 (Endovascular Engineering, Inc.) a medical device company advancing endovascular therapies for the treatment of venous thrombo-embolism (VTE), today announced the appointment of Justin Farry as its new Chief Financial Officer. A...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Endovascular Engineering
Sign Up For FreeTo access detailed company insights
Headquartered in Menlo Park, CA, Endovascular Engineering is a mission-driven, venture-backed company focused on the development and deployment of next generation clot removal technologies that target venous thromboembolism.... Read More
